<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00175</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;B&hyph;4. Principal Investigator (PI)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> On behalf of the institution, the Principal Investigator is responsible for full  <!-- PJG 0012 frnewline --> compliance with the NIH Guidelines in the conduct of recombinant DNA research.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;a. General Responsibilities  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> As part of this general responsibility, the Principal Investigator shall:  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;a&hyph;(1). Initiate or modify no recombinant DNA research which  <!-- PJG 0012 frnewline --> requires Institutional Biosafety Committee approval prior to initiation (see Sections  <!-- PJG 0012 frnewline --> III&hyph;A, III&hyph;B, and III&hyph;C) until that research or the proposed modification thereof has  <!-- PJG 0012 frnewline --> been approved by the Institutional Biosafety Committee and has met all other  <!-- PJG 0012 frnewline --> requirements of the NIH Guidelines;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;a&hyph;(2). Determine whether experiments are covered by Section III&hyph;D  <!-- PJG 0012 frnewline --> and that the appropriate procedures are followed;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;a&hyph;(3). Report any significant problems, violations of the NIH  <!-- PJG 0012 frnewline --> Guidelines, or any significant research&hyph;related accidents and illnesses to the  <!-- PJG 0012 frnewline --> Biological Safety Officer (where applicable), Greenhouse/Animal Facility Director  <!-- PJG 0012 frnewline --> (where applicable), Institutional Biosafety Committee, NIH/ORDA, and other  <!-- PJG 0012 frnewline --> appropriate authorities (if applicable) within 30 days (reports to NIH/ORDA shall  <!-- PJG 0012 frnewline --> be sent to the Office of Recombinant DNA Activities, National Institutes of Health,  <!-- PJG 0012 frnewline --> Building 31, Room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838);  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;a&hyph;(4). Report any new information bearing on the NIH Guidelines to  <!-- PJG 0012 frnewline --> the Institutional Biosafety Committee and to NIH/ORDA (reports to NIH/ORDA  <!-- PJG 0012 frnewline --> shall be sent to the Office of Recombinant DNA Activities, National Institutes of  <!-- PJG 0012 frnewline --> Health, Building 31, Room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838);  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;a&hyph;(5). Be adequately trained in good microbiological techniques;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;a&hyph;(6). Adhere to Institutional Biosafety Committee&hyph;approved  <!-- PJG 0012 frnewline --> emergency plans for handling accidental spills and personnel contamination; and  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;a&hyph;(7). Comply with shipping requirements for recombinant DNA  <!-- PJG 0012 frnewline --> molecules (see Appendix H for shipping requirements and the Laboratory Safety  <!-- PJG 0012 frnewline --> Monograph for technical recommendations).  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;b. Submissions by the Principal Investigator to the NIH/ORDA  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The Principal Investigator shall:  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;b&hyph;(1). Submit information to NIH/ORDA for certification of new  <!-- PJG 0012 frnewline --> host&hyph;vector systems;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;b&hyph;(2). Petition NIH/ORDA, with notice to the Institutional  <!-- PJG 0012 frnewline --> Biosafety Committee, for proposed exemptions to the NIH Guidelines;  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;b&hyph;(3). Petition NIH/ORDA, with concurrence of the Institutional  <!-- PJG 0012 frnewline --> Biosafety Committee, for approval to conduct experiments specified in Sections III&hyph;A and III&hyph;B of the NIH Guidelines;  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;b&hyph;(4). Petition NIH/ORDA for determination of containment for  <!-- PJG 0012 frnewline --> experiments requiring case&hyph;by&hyph;case review; and  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;b&hyph;(5). Petition NIH/ORDA for determination of containment for  <!-- PJG 0012 frnewline --> experiments not covered by the NIH Guidelines.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;c. Submissions by the Principal Investigator to the Institutional  <!-- PJG 0012 frnewline --> Biosafety Committee  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The Principal Investigator shall:  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;c&hyph;(1). Make an initial determination of the required levels of  <!-- PJG 0012 frnewline --> physical and biological containment in accordance with the NIH Guidelines;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;c&hyph;(2). Select appropriate microbiological practices and laboratory  <!-- PJG 0012 frnewline --> techniques to be used for the research;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;c&hyph;(3). Submit the initial research protocol and any subsequent  <!-- PJG 0012 frnewline --> changes (e.g., changes in the source of DNA or host&hyph;vector system), if covered under  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Sections III&hyph;A, III&hyph;B, III&hyph;C, or III&hyph;D, to the Institutional Biosafety Committee for  <!-- PJG 0012 frnewline --> review and approval or disapproval; and  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;c&hyph;(4). Remain in communication with the Institutional Biosafety  <!-- PJG 0012 frnewline --> Committee throughout the conduct of the project.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;d. Responsibilities of the Principal Investigator Prior to Initiating  <!-- PJG 0012 frnewline --> Research  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The Principal Investigator shall:  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;d&hyph;(1). Make available to all laboratory staff the protocols that  <!-- PJG 0012 frnewline --> describe the potential biohazards and the precautions to be taken;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;d&hyph;(2). Instruct and train laboratory staff in: (i) the practices and  <!-- PJG 0012 frnewline --> techniques required to ensure safety, and (ii) the procedures for dealing with  <!-- PJG 0012 frnewline --> accidents; and  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;d&hyph;(3). Inform the laboratory staff of the reasons and provisions for  <!-- PJG 0012 frnewline --> any precautionary medical practices advised or requested (e.g., vaccinations or  <!-- PJG 0012 frnewline --> serum collection).  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;B&hyph;4&hyph;e. Responsibilities of the Principal Investigator During the Conduct  <!-- PJG 0012 frnewline --> of the Research  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The Principal Investigator shall:  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;e&hyph;(1). Supervise the safety performance of the laboratory staff to  <!-- PJG 0012 frnewline --> ensure that the required safety practices and techniques are employed;  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;e&hyph;(2). Investigate and report any significant problems pertaining to  <!-- PJG 0012 frnewline --> the operation and implementation of containment practices and procedures in  <!-- PJG 0012 frnewline --> writing to the Biological Safety Officer (where applicable), Greenhouse/Animal  <!-- PJG 0012 frnewline --> Facility Director (where applicable), the Institutional Biosafety Committee,  <!-- PJG 0012 frnewline --> NIH/ORDA, and other appropriate authorities (if applicable) (reports to the  <!-- PJG 0012 frnewline --> NIH/ORDA shall be sent to the Office of Recombinant DNA Activities, National  <!-- PJG 0012 frnewline --> Institutes of Health, Building 31, Room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838);  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;e&hyph;(3). Correct work errors and conditions that may result in the  <!-- PJG 0012 frnewline --> release of recombinant DNA materials; and  <!-- PJG 0012 frnewline --> Section IV&hyph;B&hyph;4&hyph;e&hyph;(4). Ensure the integrity of the physical containment (e.g.,  <!-- PJG 0012 frnewline --> biological safety cabinets) and the biological containment (e.g., purity and genotypic  <!-- PJG 0012 frnewline --> and phenotypic characteristics).  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;C. Responsibilities of the National Institutes of Health (NIH)  <!-- PJG 0012 frnewline --> Section IV&hyph;C&hyph;1. NIH Director  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The NIH Director is responsible for: (i) establishing the NIH Guidelines, (ii)  <!-- PJG 0012 frnewline --> overseeing their implementation, and (iii) their final interpretation. The NIH  <!-- PJG 0012 frnewline --> Director has responsibilities under the NIH Guidelines that involve ORDA and the  <!-- PJG 0012 frnewline --> RAC. ORDA's responsibilities under the NIH Guidelines are administrative.  <!-- PJG 0012 frnewline --> Advice from the RAC is primarily scientific, technical, and ethical. In certain  <!-- PJG 0012 frnewline --> circumstances, there is specific opportunity for public comment with published  <!-- PJG 0012 frnewline --> response prior to final action.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Section IV&hyph;C&hyph;1&hyph;a. General Responsibilities  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            